The biotech sector, which has outperformed over the last few years, has not exactly had a great start this year — the NASDAQ …
To kick off biotech in 2016, analyst Joshua Schimmer of Piper Jaffray pounds the table on both Gilead Sciences, Inc. (NASDAQ:GILD) and Amgen, …
Unilife Corp (NASDAQ: UNIS) is having an incredible day in the market today after disclosing an SEC filing with regard to an exclusivity agreement with Amgen, …
Apple Inc. (NASDAQ:AAPL) was trading down 1% to about $111 in pre-market trading this morning following news that competitor Samsung is appealing the U.
Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc.
Amgen, Inc. (NASDAQ:AMGN) announced the U.
Amgen, Inc. (NASDAQ:AMGN) announced it will present data from its oncology portfolio and pipeline at the European Cancer Congress 2015 (ECC 2015), Sept.
Amgen, Inc. (NASDAQ:AMGN) announced the submission of an application to the U.
A number of Wall Street analysts weighed in on their favorite stocks this morning before market open. Below are the most notable analyst …
Amgen, Inc.’s (NASDAQ:AMGN) cholesterol-reducing drug, Repatha, was approved by the FDA last week, nearly a month after it was already approved by European …
